img

Global Small Nucleic Acid Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Small Nucleic Acid Drug Market Insights, Forecast to 2034

The global Small Nucleic Acid Drug market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Small Nucleic Acid Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Small Nucleic Acid Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Small Nucleic Acid Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Small Nucleic Acid Drug include Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Small Nucleic Acid Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Small Nucleic Acid Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Small Nucleic Acid Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Small Nucleic Acid Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Small Nucleic Acid Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Small Nucleic Acid Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku, etc.



By Company


Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
Biogen
Nippon Shinyaku
Segment by Type
siRNA Drug
ASO Drug

Segment by Application


Duchenne Muscular Dystrophy
Spinal Muscular Atrophy
Cancer
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Small Nucleic Acid Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Small Nucleic Acid Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Nucleic Acid Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Small Nucleic Acid Drug Product Introduction
1.2 Market by Type
1.2.1 Global Small Nucleic Acid Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 siRNA Drug
1.2.3 ASO Drug
1.3 Market by Application
1.3.1 Global Small Nucleic Acid Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Duchenne Muscular Dystrophy
1.3.3 Spinal Muscular Atrophy
1.3.4 Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Small Nucleic Acid Drug Sales Estimates and Forecasts 2018-2034
2.2 Global Small Nucleic Acid Drug Revenue by Region
2.2.1 Global Small Nucleic Acid Drug Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Small Nucleic Acid Drug Revenue by Region (2018-2024)
2.2.3 Global Small Nucleic Acid Drug Revenue by Region (2024-2034)
2.2.4 Global Small Nucleic Acid Drug Revenue Market Share by Region (2018-2034)
2.3 Global Small Nucleic Acid Drug Sales Estimates and Forecasts 2018-2034
2.4 Global Small Nucleic Acid Drug Sales by Region
2.4.1 Global Small Nucleic Acid Drug Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Small Nucleic Acid Drug Sales by Region (2018-2024)
2.4.3 Global Small Nucleic Acid Drug Sales by Region (2024-2034)
2.4.4 Global Small Nucleic Acid Drug Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Small Nucleic Acid Drug Sales by Manufacturers
3.1.1 Global Small Nucleic Acid Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Small Nucleic Acid Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Small Nucleic Acid Drug in 2022
3.2 Global Small Nucleic Acid Drug Revenue by Manufacturers
3.2.1 Global Small Nucleic Acid Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Small Nucleic Acid Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Small Nucleic Acid Drug Revenue in 2022
3.3 Global Key Players of Small Nucleic Acid Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Small Nucleic Acid Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Small Nucleic Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Small Nucleic Acid Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Small Nucleic Acid Drug, Product Offered and Application
3.8 Global Key Manufacturers of Small Nucleic Acid Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Small Nucleic Acid Drug Sales by Type
4.1.1 Global Small Nucleic Acid Drug Historical Sales by Type (2018-2024)
4.1.2 Global Small Nucleic Acid Drug Forecasted Sales by Type (2024-2034)
4.1.3 Global Small Nucleic Acid Drug Sales Market Share by Type (2018-2034)
4.2 Global Small Nucleic Acid Drug Revenue by Type
4.2.1 Global Small Nucleic Acid Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Small Nucleic Acid Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Small Nucleic Acid Drug Revenue Market Share by Type (2018-2034)
4.3 Global Small Nucleic Acid Drug Price by Type
4.3.1 Global Small Nucleic Acid Drug Price by Type (2018-2024)
4.3.2 Global Small Nucleic Acid Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Small Nucleic Acid Drug Sales by Application
5.1.1 Global Small Nucleic Acid Drug Historical Sales by Application (2018-2024)
5.1.2 Global Small Nucleic Acid Drug Forecasted Sales by Application (2024-2034)
5.1.3 Global Small Nucleic Acid Drug Sales Market Share by Application (2018-2034)
5.2 Global Small Nucleic Acid Drug Revenue by Application
5.2.1 Global Small Nucleic Acid Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Small Nucleic Acid Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Small Nucleic Acid Drug Revenue Market Share by Application (2018-2034)
5.3 Global Small Nucleic Acid Drug Price by Application
5.3.1 Global Small Nucleic Acid Drug Price by Application (2018-2024)
5.3.2 Global Small Nucleic Acid Drug Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Small Nucleic Acid Drug Market Size by Type
6.1.1 US & Canada Small Nucleic Acid Drug Sales by Type (2018-2034)
6.1.2 US & Canada Small Nucleic Acid Drug Revenue by Type (2018-2034)
6.2 US & Canada Small Nucleic Acid Drug Market Size by Application
6.2.1 US & Canada Small Nucleic Acid Drug Sales by Application (2018-2034)
6.2.2 US & Canada Small Nucleic Acid Drug Revenue by Application (2018-2034)
6.3 US & Canada Small Nucleic Acid Drug Market Size by Country
6.3.1 US & Canada Small Nucleic Acid Drug Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Small Nucleic Acid Drug Sales by Country (2018-2034)
6.3.3 US & Canada Small Nucleic Acid Drug Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Small Nucleic Acid Drug Market Size by Type
7.1.1 Europe Small Nucleic Acid Drug Sales by Type (2018-2034)
7.1.2 Europe Small Nucleic Acid Drug Revenue by Type (2018-2034)
7.2 Europe Small Nucleic Acid Drug Market Size by Application
7.2.1 Europe Small Nucleic Acid Drug Sales by Application (2018-2034)
7.2.2 Europe Small Nucleic Acid Drug Revenue by Application (2018-2034)
7.3 Europe Small Nucleic Acid Drug Market Size by Country
7.3.1 Europe Small Nucleic Acid Drug Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Small Nucleic Acid Drug Sales by Country (2018-2034)
7.3.3 Europe Small Nucleic Acid Drug Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Small Nucleic Acid Drug Market Size
8.1.1 China Small Nucleic Acid Drug Sales (2018-2034)
8.1.2 China Small Nucleic Acid Drug Revenue (2018-2034)
8.2 China Small Nucleic Acid Drug Market Size by Application
8.2.1 China Small Nucleic Acid Drug Sales by Application (2018-2034)
8.2.2 China Small Nucleic Acid Drug Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Small Nucleic Acid Drug Market Size by Type
9.1.1 Asia Small Nucleic Acid Drug Sales by Type (2018-2034)
9.1.2 Asia Small Nucleic Acid Drug Revenue by Type (2018-2034)
9.2 Asia Small Nucleic Acid Drug Market Size by Application
9.2.1 Asia Small Nucleic Acid Drug Sales by Application (2018-2034)
9.2.2 Asia Small Nucleic Acid Drug Revenue by Application (2018-2034)
9.3 Asia Small Nucleic Acid Drug Sales by Region
9.3.1 Asia Small Nucleic Acid Drug Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Small Nucleic Acid Drug Revenue by Region (2018-2034)
9.3.3 Asia Small Nucleic Acid Drug Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Small Nucleic Acid Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Small Nucleic Acid Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Information
11.1.2 Ionis Pharmaceuticals Overview
11.1.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Ionis Pharmaceuticals Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ionis Pharmaceuticals Recent Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Information
11.2.2 Sarepta Therapeutics Overview
11.2.3 Sarepta Therapeutics Small Nucleic Acid Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sarepta Therapeutics Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sarepta Therapeutics Recent Developments
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Company Information
11.3.2 Alnylam Pharmaceuticals Overview
11.3.3 Alnylam Pharmaceuticals Small Nucleic Acid Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Alnylam Pharmaceuticals Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Alnylam Pharmaceuticals Recent Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Overview
11.4.3 Biogen Small Nucleic Acid Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Biogen Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biogen Recent Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Information
11.5.2 Nippon Shinyaku Overview
11.5.3 Nippon Shinyaku Small Nucleic Acid Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Nippon Shinyaku Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nippon Shinyaku Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Small Nucleic Acid Drug Industry Chain Analysis
12.2 Small Nucleic Acid Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Small Nucleic Acid Drug Production Mode & Process
12.4 Small Nucleic Acid Drug Sales and Marketing
12.4.1 Small Nucleic Acid Drug Sales Channels
12.4.2 Small Nucleic Acid Drug Distributors
12.5 Small Nucleic Acid Drug Customers
13 Market Dynamics
13.1 Small Nucleic Acid Drug Industry Trends
13.2 Small Nucleic Acid Drug Market Drivers
13.3 Small Nucleic Acid Drug Market Challenges
13.4 Small Nucleic Acid Drug Market Restraints
14 Key Findings in The Global Small Nucleic Acid Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Small Nucleic Acid Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of siRNA Drug
Table 3. Major Manufacturers of ASO Drug
Table 4. Global Small Nucleic Acid Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Small Nucleic Acid Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Small Nucleic Acid Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Small Nucleic Acid Drug Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Small Nucleic Acid Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Small Nucleic Acid Drug Revenue Market Share by Region (2024-2034)
Table 10. Global Small Nucleic Acid Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Small Nucleic Acid Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Small Nucleic Acid Drug Sales by Region (2024-2034) & (K Units)
Table 13. Global Small Nucleic Acid Drug Sales Market Share by Region (2018-2024)
Table 14. Global Small Nucleic Acid Drug Sales Market Share by Region (2024-2034)
Table 15. Global Small Nucleic Acid Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Small Nucleic Acid Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Small Nucleic Acid Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Small Nucleic Acid Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Small Nucleic Acid Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Small Nucleic Acid Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Small Nucleic Acid Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Small Nucleic Acid Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid Drug as of 2022)
Table 23. Global Key Manufacturers of Small Nucleic Acid Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Small Nucleic Acid Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Small Nucleic Acid Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Small Nucleic Acid Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Small Nucleic Acid Drug Sales by Type (2024-2034) & (K Units)
Table 29. Global Small Nucleic Acid Drug Sales Share by Type (2018-2024)
Table 30. Global Small Nucleic Acid Drug Sales Share by Type (2024-2034)
Table 31. Global Small Nucleic Acid Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Small Nucleic Acid Drug Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Small Nucleic Acid Drug Revenue Share by Type (2018-2024)
Table 34. Global Small Nucleic Acid Drug Revenue Share by Type (2024-2034)
Table 35. Small Nucleic Acid Drug Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Small Nucleic Acid Drug Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Small Nucleic Acid Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Small Nucleic Acid Drug Sales by Application (2024-2034) & (K Units)
Table 39. Global Small Nucleic Acid Drug Sales Share by Application (2018-2024)
Table 40. Global Small Nucleic Acid Drug Sales Share by Application (2024-2034)
Table 41. Global Small Nucleic Acid Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Small Nucleic Acid Drug Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Small Nucleic Acid Drug Revenue Share by Application (2018-2024)
Table 44. Global Small Nucleic Acid Drug Revenue Share by Application (2024-2034)
Table 45. Small Nucleic Acid Drug Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Small Nucleic Acid Drug Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Small Nucleic Acid Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Small Nucleic Acid Drug Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Small Nucleic Acid Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Small Nucleic Acid Drug Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Small Nucleic Acid Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Small Nucleic Acid Drug Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Small Nucleic Acid Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Small Nucleic Acid Drug Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Small Nucleic Acid Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Small Nucleic Acid Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Small Nucleic Acid Drug Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Small Nucleic Acid Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Small Nucleic Acid Drug Sales by Country (2024-2034) & (K Units)
Table 60. Europe Small Nucleic Acid Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Small Nucleic Acid Drug Sales by Type (2024-2034) & (K Units)
Table 62. Europe Small Nucleic Acid Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Small Nucleic Acid Drug Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Small Nucleic Acid Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Small Nucleic Acid Drug Sales by Application (2024-2034) & (K Units)
Table 66. Europe Small Nucleic Acid Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Small Nucleic Acid Drug Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Small Nucleic Acid Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Small Nucleic Acid Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Small Nucleic Acid Drug Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Small Nucleic Acid Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Small Nucleic Acid Drug Sales by Country (2024-2034) & (K Units)
Table 73. China Small Nucleic Acid Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Small Nucleic Acid Drug Sales by Type (2024-2034) & (K Units)
Table 75. China Small Nucleic Acid Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Small Nucleic Acid Drug Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Small Nucleic Acid Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Small Nucleic Acid Drug Sales by Application (2024-2034) & (K Units)
Table 79. China Small Nucleic Acid Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Small Nucleic Acid Drug Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Small Nucleic Acid Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Small Nucleic Acid Drug Sales by Type (2024-2034) & (K Units)
Table 83. Asia Small Nucleic Acid Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Small Nucleic Acid Drug Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Small Nucleic Acid Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Small Nucleic Acid Drug Sales by Application (2024-2034) & (K Units)
Table 87. Asia Small Nucleic Acid Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Small Nucleic Acid Drug Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Small Nucleic Acid Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Small Nucleic Acid Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Small Nucleic Acid Drug Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Small Nucleic Acid Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Small Nucleic Acid Drug Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales by Country (2024-2034) & (K Units)
Table 107. Ionis Pharmaceuticals Company Information
Table 108. Ionis Pharmaceuticals Description and Major Businesses
Table 109. Ionis Pharmaceuticals Small Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Ionis Pharmaceuticals Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Ionis Pharmaceuticals Recent Developments
Table 112. Sarepta Therapeutics Company Information
Table 113. Sarepta Therapeutics Description and Major Businesses
Table 114. Sarepta Therapeutics Small Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sarepta Therapeutics Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sarepta Therapeutics Recent Developments
Table 117. Alnylam Pharmaceuticals Company Information
Table 118. Alnylam Pharmaceuticals Description and Major Businesses
Table 119. Alnylam Pharmaceuticals Small Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Alnylam Pharmaceuticals Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Alnylam Pharmaceuticals Recent Developments
Table 122. Biogen Company Information
Table 123. Biogen Description and Major Businesses
Table 124. Biogen Small Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Biogen Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Biogen Recent Developments
Table 127. Nippon Shinyaku Company Information
Table 128. Nippon Shinyaku Description and Major Businesses
Table 129. Nippon Shinyaku Small Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Nippon Shinyaku Small Nucleic Acid Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Nippon Shinyaku Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Small Nucleic Acid Drug Distributors List
Table 135. Small Nucleic Acid Drug Customers List
Table 136. Small Nucleic Acid Drug Market Trends
Table 137. Small Nucleic Acid Drug Market Drivers
Table 138. Small Nucleic Acid Drug Market Challenges
Table 139. Small Nucleic Acid Drug Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Nucleic Acid Drug Product Picture
Figure 2. Global Small Nucleic Acid Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Small Nucleic Acid Drug Market Share by Type in 2022 & 2034
Figure 4. siRNA Drug Product Picture
Figure 5. ASO Drug Product Picture
Figure 6. Global Small Nucleic Acid Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Small Nucleic Acid Drug Market Share by Application in 2022 & 2034
Figure 8. Duchenne Muscular Dystrophy
Figure 9. Spinal Muscular Atrophy
Figure 10. Cancer
Figure 11. Others
Figure 12. Small Nucleic Acid Drug Report Years Considered
Figure 13. Global Small Nucleic Acid Drug Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Small Nucleic Acid Drug Revenue 2018-2034 (US$ Million)
Figure 15. Global Small Nucleic Acid Drug Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Small Nucleic Acid Drug Revenue Market Share by Region (2018-2034)
Figure 17. Global Small Nucleic Acid Drug Sales 2018-2034 ((K Units)
Figure 18. Global Small Nucleic Acid Drug Sales Market Share by Region (2018-2034)
Figure 19. US & Canada Small Nucleic Acid Drug Sales YoY (2018-2034) & (K Units)
Figure 20. US & Canada Small Nucleic Acid Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Small Nucleic Acid Drug Sales YoY (2018-2034) & (K Units)
Figure 22. Europe Small Nucleic Acid Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Small Nucleic Acid Drug Sales YoY (2018-2034) & (K Units)
Figure 24. China Small Nucleic Acid Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Asia (excluding China) Small Nucleic Acid Drug Sales YoY (2018-2034) & (K Units)
Figure 26. Asia (excluding China) Small Nucleic Acid Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Small Nucleic Acid Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Small Nucleic Acid Drug in the World: Market Share by Small Nucleic Acid Drug Revenue in 2022
Figure 31. Global Small Nucleic Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Small Nucleic Acid Drug Sales Market Share by Type (2018-2034)
Figure 33. Global Small Nucleic Acid Drug Revenue Market Share by Type (2018-2034)
Figure 34. Global Small Nucleic Acid Drug Sales Market Share by Application (2018-2034)
Figure 35. Global Small Nucleic Acid Drug Revenue Market Share by Application (2018-2034)
Figure 36. US & Canada Small Nucleic Acid Drug Sales Market Share by Type (2018-2034)
Figure 37. US & Canada Small Nucleic Acid Drug Revenue Market Share by Type (2018-2034)
Figure 38. US & Canada Small Nucleic Acid Drug Sales Market Share by Application (2018-2034)
Figure 39. US & Canada Small Nucleic Acid Drug Revenue Market Share by Application (2018-2034)
Figure 40. US & Canada Small Nucleic Acid Drug Revenue Share by Country (2018-2034)
Figure 41. US & Canada Small Nucleic Acid Drug Sales Share by Country (2018-2034)
Figure 42. U.S. Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Small Nucleic Acid Drug Sales Market Share by Type (2018-2034)
Figure 45. Europe Small Nucleic Acid Drug Revenue Market Share by Type (2018-2034)
Figure 46. Europe Small Nucleic Acid Drug Sales Market Share by Application (2018-2034)
Figure 47. Europe Small Nucleic Acid Drug Revenue Market Share by Application (2018-2034)
Figure 48. Europe Small Nucleic Acid Drug Revenue Share by Country (2018-2034)
Figure 49. Europe Small Nucleic Acid Drug Sales Share by Country (2018-2034)
Figure 50. Germany Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 51. France Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 52. U.K. Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 53. Italy Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 54. Russia Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 55. China Small Nucleic Acid Drug Sales Market Share by Type (2018-2034)
Figure 56. China Small Nucleic Acid Drug Revenue Market Share by Type (2018-2034)
Figure 57. China Small Nucleic Acid Drug Sales Market Share by Application (2018-2034)
Figure 58. China Small Nucleic Acid Drug Revenue Market Share by Application (2018-2034)
Figure 59. Asia Small Nucleic Acid Drug Sales Market Share by Type (2018-2034)
Figure 60. Asia Small Nucleic Acid Drug Revenue Market Share by Type (2018-2034)
Figure 61. Asia Small Nucleic Acid Drug Sales Market Share by Application (2018-2034)
Figure 62. Asia Small Nucleic Acid Drug Revenue Market Share by Application (2018-2034)
Figure 63. Asia Small Nucleic Acid Drug Revenue Share by Region (2018-2034)
Figure 64. Asia Small Nucleic Acid Drug Sales Share by Region (2018-2034)
Figure 65. Japan Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 66. South Korea Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 67. China Taiwan Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 68. Southeast Asia Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 69. India Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Small Nucleic Acid Drug Revenue Share by Country (2018-2034)
Figure 75. Middle East, Africa and Latin America Small Nucleic Acid Drug Sales Share by Country (2018-2034)
Figure 76. Brazil Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 77. Mexico Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Turkey Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 79. Israel Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 80. GCC Countries Small Nucleic Acid Drug Revenue (2018-2034) & (US$ Million)
Figure 81. Small Nucleic Acid Drug Value Chain
Figure 82. Small Nucleic Acid Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries